Liver steatosis in celiac disease: The open door

Minerva Gastroenterologica e Dietologica

Volumn 59, Issue 1, 2013, Pages 89-95

  Abenavoli, L ^a   Luigiano, C ^b   Larussa, T ^a   Milic, N ^c   De Lorenzo, A ^d   Stelitano, L ^e   Morace, C ^e   Consolo, P ^e   Miraglia, S ^b   Fagoonee, S ^f   Virgilio, C ^b   Luzza, F ^a   Pellicano, R ^g  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b ARNAS Garibaldi   (Italy)

^c UNIVERSITY OF NOVI SAD   (Serbia)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g MOLINETTE HOSPITAL   (Italy)

Author keywords

Celiac disease; Diet, gluten free; Fatty liver; Malabsorption syndromes; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELIAC DISEASE; CELL STIMULATION; DIABETES MELLITUS; DISEASE COURSE; FATTY LIVER; GASTROINTESTINAL TRACT; GLUTEN FREE DIET; HUMAN; KUPFFER CELL; LIVER FUNCTION; MALABSORPTION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; REVIEW; SCREENING;

CELIAC DISEASE; DIET, GLUTEN-FREE; FATTY LIVER; HUMANS;

EID: 84876593363     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010;28:155-61.
2. Petta S, Muratore C, Craxì A. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis 2009;41:615-25.
3. Angulo P. Non-alcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
4. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:521-33, viii. (Pubitemid 39141140)
5. Garinis GA, Fruci B, Mazza A, De Siena M, Abenavoli S, Gulletta E, et al. Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. Int J Obes (Lond) 2010;34:1255-64.
6. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S et al. Association between innate response to gliadin and activation of pathogenic T cells in celiac disease. Lancet 2003;362:30-7. (Pubitemid 36835817)
7. Vilppula A, Kaukinen K, Luostarinen L, Krekelä I, Patrikainen H, Valve R, et al. Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol 2009;9:49.
8. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-43.
9. Bardella MT, Valenti L, Pagliari C, Peracchi M, Fare M, Fracanzani AL et al. Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig Liver Dis 2004;36:333-6. (Pubitemid 41115463)
10. Caldwell S, Argo C. The natural history of non-alcoholic fatty liver disease. Dig Dis 2010;28162-8.
11. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292:G518-G525.
12. Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int 2006;26:1021-8. (Pubitemid 44541742)
13. Montalto M, D'Onofrio F, Gallo A, Cazzato A, Gasbarrini G. Intestinal microbiota and its functions. Dig Liver Dis Suppl 2009;3:30-4.
14. Sydora BC, Martin SM, Lupicki M, Dieleman LA, Doyle J, Walker JW et al. Bacterial antigens alone can influence intestinal barrier integrity, but live bacteria are required for initiation of intestinal inflammation and injury. Inflamm Bowel Dis 2006;12:429-36.
15. Di Cagno R, De Angelis M, De Pasquale I, Ndagijimana M, Vernocchi P, Ricciuti P et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol 2011;11:219.
16. Nolan JP. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 2010;52:1829-35.
17. Uhrig A, Banafsche R, Kremer M, Hegenbarth S, Hamann A, Neurath M et al. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J Leukoc Biol 2005;77:626-33. (Pubitemid 40628742)
18. Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny M et al. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int 2008; 28:1026-33. (Pubitemid 352044451)
19. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007;292:E740-E747. (Pubitemid 46411051)
20. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994;20:453-60. (Pubitemid 24233374)
21. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-24.
22. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-01.
23. Duggan JM, Duggan AE. Systematic review: The liver in celiac disease. Aliment Pharmacol Ther 2005;21:515-8. (Pubitemid 40381501)
24. Hagander B, Brandt L, Sjolund K, Berg NO, Nordén Å Stenstam M. Hepatic injury in adult coeliac disease. Lancet 1977;2:270-2. (Pubitemid 8152956)
25. Dalekos GN, Bogdanos DP, Neuberger J. Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message? Liver Int 2008;28:426-8. (Pubitemid 351411127)
26. Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H. Prealence and clinical importance of hypertransaminaseaemia in coeliac disease. Eur J Gastroenterol Hepatol 1999;11:283-8. (Pubitemid 29286682)
27. Shaoul R, Lerner A. Associated autoantibodies in celiac disease. Autoimmun Rev 2007;6:559-65. (Pubitemid 47374617)
28. Rubio-Tapia A, Murray JA. Liver involvement in celiac disease. Minerva Med 2008;99:595-04.
29. Maggiore G, Caprai S. The Liver in celiac disease. J Pediatr Gastroenterol Nutr 2003;37:117-9. (Pubitemid 39274534)
30. Lawson A, West J, Aithal GP, Logan RF. Autoimmune cholestatic liver disease in people with celiac disease: a population-based study of their association. Aliment Pharmacol Ther 2005;21:401-5. (Pubitemid 40313942)
31. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009;49:1877-87.
32. Korponay-Szabo IR, Halttunen T, Szalai Z Laurila K, Király R, Kovács JB et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004;53:641-8. (Pubitemid 38561440)
33. Zali MR, Rostami Nejad M, Rostami K, Alavian SM. Liver complications in celiac disease. Hepat Mon 2011;11:333-41.
34. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001;48:206-11. (Pubitemid 32141844)
35. Nehra V, Angulo P, Buchman AL, Lindor KD. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci 2001;46:2347-52. (Pubitemid 33042332)
36. Grieco A, Miele L, Pignatoro G, Pompili M, Rapaccini GL, Gasbarrini G. Is coeliac disease a confounding factor in the diagnosis of NASH? Gut 2001;49:596. (Pubitemid 32896995)
37. Loiacono O, Petta S, Venezia G, Di Marco V, Tarantino G, Barbaria F et al. Anti-tissue transglutaminase antibodies in patients with abnormal liver test: is it always celiac disease? Am J Gastroenterol 2005;100:2472-7.
38. Rahimi AR, Daryani NE, Ghofrani H, Taher M, Pashaei MR, Abdollahzade S et al. The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran. Turk J Gastroenterol 2011;22:300-4.
39. Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta ML, Unalp-Arida A, Tonascia J et al. NASH Clinical Research Network. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010;52:913-24.
40. Bardella MT, Fredella C, Prampolini L, Molteni N, Giunta AM, Bianchi PA. Body composition and dietary intakes in adult celiac disease patients consuming a strict gluten-free diet. Am J Clin Nutrition 2000;72:937-9.
41. Kabbani TA, Goldberg A, Kelly CP, Pallav K, Tariq S, Peer A et al. Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther 2012;35:723-9.
42. Mariani P, Viti MG, Montuori M, La Vecchia A, Cipolletta E, Calvani L et al. The gluten-free diet: a nutritional risk factor for adolescents with celiac disease? J Pediatr Gastroenterol Nutr 1998;27:19-23.
43. Ferrara P, Cicala M, Tiberi E, Spadaccio C, Marcella L, Gatto A et al. High fat consumption in children with celiac disease. Acta Gastroenterol Belg 2009;72:296-300.
44. Valletta E, Fornaro M, Cipolli M, Conte S, Bissolo F, Danchielli C. Celiac disease and obesity: need for nutritional follow-up after diagnosis. Eur J Clin Nutr 2010;64:1371-2.
45. Abenavoli L, Arena V, Giancotti F, Vecchio FM, Abenavoli S. Celiac disease, primary biliary cirrhosis and helicobacter pylori infection: one link for three diseases. Int J Immunopathol Pharmacol 2010;23:1261-5.